Candace Todd

Candace Todd is a seasoned professional with extensive experience in commercial operations and product strategy within the biotechnology and pharmaceutical sectors. Currently serving as Senior Manager of Commercial Operations at Revolution Medicines since March 2025, Todd previously held the role of Manager of Global Product Strategy & Commercialization at Biogen, where significant contributions included leading a research initiative for Zurzuvae’s ex-US launch and developing a comprehensive strategic plan for the MS franchise. Experience at Gilead Sciences as an MBA intern focused on market research analysis for COVID-19 product strategies, while earlier roles included improving asset management at Novartis and conducting molecular virology research at the University of California San Diego. Todd holds an MBA from UCLA Anderson School of Management and a Bachelor's Degree in Biology with a minor in Psychology from Haverford College.